Clinical trial · Interventional
Brain Metastasis Development Mechanism in BCBM Patients
Evaluation of Brain Metastasis Development Mechanism in Patients With Breast Cancer With Brain Metastasis(BCBM)
NCT06330870CI-TRIAL-00075427recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is the experimental study for brain metastasis development mechanism in patients with breast cancer with brain metastasis
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Metastasis | — | UNRESOLVED | — |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| WGS/TME evaluation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- WGS/TME evaluation
- description
- This is not intervention clinical trial design. We explore whole genome sequencing and tumor microenvironment evaluation for brain metastasis specimen in breast cancer patients.
- interventionNames
- Procedure: WGS/TME evaluation
Primary outcomes (1)
- measure
- Intracranial disease free survival
- timeFrame
- Months
- description
- Time to new brain metastasis or brain metastasis progression from the brain surgery
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: * Breast cancer * Brain metastasis curative surgery patient Exclusion Criteria: * Gamma Knife surgery patient
References
Publications (0)
Data not yet available
No reference posted for this study.